1. Home
  2. XLO vs MBBC Comparison

XLO vs MBBC Comparison

Compare XLO & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.48

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$14.50

Market Cap

40.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XLO
MBBC
Founded
2016
1902
Country
United States
United States
Employees
N/A
35
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
40.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
XLO
MBBC
Price
$8.48
$14.50
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
33.3K
15.4K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,766,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
N/A
P/E Ratio
N/A
$47.11
Revenue Growth
589.88
N/A
52 Week Low
$0.46
$9.94
52 Week High
$9.25
$15.75

Technical Indicators

Market Signals
Indicator
XLO
MBBC
Relative Strength Index (RSI) 60.59 50.03
Support Level $0.62 $12.93
Resistance Level $8.66 $15.39
Average True Range (ATR) 0.50 0.60
MACD -0.05 -0.02
Stochastic Oscillator 68.13 23.78

Price Performance

Historical Comparison
XLO
MBBC

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

Share on Social Networks: